Theratechnologies (Theratechnologies) Treasury Stock : $0.00 Mil (As of Feb. 2024)

View and export this data going back to 2011. Start your Free Trial

What is Theratechnologies Treasury Stock?

Treasury stock is the portion of shares that a company keeps in their own treasury. Theratechnologies's treasury stock for the quarter that ended in Feb. 2024 was $0.00 Mil.

Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place.

Theratechnologies Treasury Stock Historical Data

The historical data trend for Theratechnologies's Treasury Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Theratechnologies Treasury Stock Chart

Theratechnologies Annual Data

Trend

Nov14

Nov15

Nov16

Nov17

Nov18

Nov19

Nov20

Nov21

Nov22

Nov23

Treasury Stock

Get a 7-Day Free Trial

Theratechnologies Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Treasury Stock	Get a 7-Day Free Trial															-	-	-	-	-

Theratechnologies Treasury Stock Calculation

The portion of shares that a company keeps in their own treasury. Treasury stock may have come from a repurchase or buyback from shareholders; or it may have never been issued to the public in the first place. These shares don't pay dividends, have no voting rights, and should not be included in shares outstanding calculations.

Theratechnologies (Theratechnologies) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Theratechnologies Inc (NAS:THTX) » Definitions » Treasury Stock

Comparable Companies

Traded in Other Exchanges

TQ80:Germany TH:Canada

Address

2015, rue Peel, 11e etage, Montreal, QC, CAN, H3A 1T8

Website

https://www.theratech.com

Theratechnologies Inc is a specialty pharmaceutical company that addresses the unmet medical needs of HIV patients. It mainly operates in Canada and the United States. The company has two approved products, EGRIFTA marketed in Canada and the United States, and Trogarzo approved for commercialization in the United States.